Prorok; Rachel
Patent Applications and Registrations
Patent applications and USPTO patent grants for Prorok; Rachel.The latest application filed is for "progranulin variants".
- Prorok; Rachel - South San Francisco CA
| Patent | Date |
|---|---|
| Progranulin Variants App 20220220172 - Cherf; Gerald Maxwell ; et al. | 2022-07-14 |
| Progranulin Variants App 20220213155 - Cherf; Gerald Maxwell ; et al. | 2022-07-07 |
| Anti-trem2 Antibodies And Methods Of Use Thereof App 20220177576 - Dennis; Mark S. ; et al. | 2022-06-09 |
| Anti-trem2 Antibodies And Methods Of Use Thereof App 20220119522 - Dennis; Mark S. ; et al. | 2022-04-21 |
| Anti-trem2 Antibodies And Methods Of Use Thereof App 20220073609 - Dennis; Mark S. ; et al. | 2022-03-10 |
| Anti-TREM2 antibodies and methods of use thereof Grant 11,124,567 - Dennis , et al. September 21, 2 | 2021-09-21 |
| Anti-trem2 Antibodies And Methods Of Use Thereof App 20210214438 - Dennis; Mark S. ; et al. | 2021-07-15 |
| Progranulin Variants App 20210188925 - Cherf; Gerald Maxwell ; et al. | 2021-06-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 